Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]

3257 reported adverse events

Drugs of this class: LETERMOVIR

These side effects are most commonly reported by patients taking drugs of the Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] class:

# Side effect Count
0 OFF LABEL USE 718
1 DRUG INEFFECTIVE 295
2 CYTOMEGALOVIRUS INFECTION REACTIVATION 260
3 DEATH 196
4 ACUTE KIDNEY INJURY 178
5 CYTOMEGALOVIRUS INFECTION 173
6 DRUG INTERACTION 166
7 PRODUCT USE IN UNAPPROVED INDICATION 165
8 PANCYTOPENIA 153
9 DRUG RESISTANCE 99
See all common reactions for Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]

Drugs of the Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SARS-COV-2 RNA 4 0.5000
1 LUNG DISEASE INFECTIVE EXACERBATION 10 0.3704
2 GASTRITIS HERPES 3 0.3333
3 ENCEPHALITIS CYTOMEGALOVIRUS 75 0.1712
4 RETINITIS VIRAL 16 0.1322
5 HCOV-OC43 INFECTION 4 0.1290
6 AUTOIMMUNE PANCYTOPENIA 10 0.1099
7 HEPATIC HYPERTROPHY 3 0.0938
8 QUADRANTANOPIA 10 0.0763
9 HUMAN HERPESVIRUS 6 VIRAEMIA 3 0.0750
See all enriched reactions for Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]